Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Molecular Epidemiology of Invasive Staphylococcus aureus Infections and Concordance with Colonization Isolates.

Thomsen IP, Kadari P, Soper NR, Riddell S, Kiska D, Creech CB, Shaw J.

J Pediatr. 2019 Jul;210:173-177. doi: 10.1016/j.jpeds.2019.03.004. Epub 2019 Apr 5.

PMID:
30961989
2.

Effects of Antibiotic Timing on Culture Results and Clinical Outcomes in Pediatric Musculoskeletal Infection.

Benvenuti MA, An TJ, Mignemi ME, Martus JE, Thomsen IP, Schoenecker JG.

J Pediatr Orthop. 2019 Mar;39(3):158-162. doi: 10.1097/BPO.0000000000000884.

PMID:
30730421
3.

Mupirocin for Staphylococcus aureus Decolonization of Infants in Neonatal Intensive Care Units.

Kotloff KL, Shirley DT, Creech CB, Frey SE, Harrison CJ, Staat M, Anderson EJ, Dulkerian S, Thomsen IP, Al-Hosni M, Pahud BA, Bernstein DI, Yi J, Petrikin JE, Haberman B, Stephens K, Stephens I, Oler RE Jr, Conrad TM.

Pediatrics. 2019 Jan;143(1). pii: e20181565. doi: 10.1542/peds.2018-1565.

PMID:
30587533
4.

Human mAbs to Staphylococcus aureus IsdA Provide Protection Through Both Heme-Blocking and Fc-Mediated Mechanisms.

Bennett MR, Bombardi RG, Kose N, Parrish EH, Nagel MB, Petit RA, Read TD, Schey KL, Thomsen IP, Skaar EP, Crowe JE.

J Infect Dis. 2019 Apr 8;219(8):1264-1273. doi: 10.1093/infdis/jiy635.

PMID:
30496483
5.

Prevalence of Staphylococcus aureus and Use of Antistaphylococcal Therapy in Children Hospitalized with Pneumonia.

Frush JM, Zhu Y, Edwards KM, Grijalva CG, Thomsen IP, Self WH, Jain S, Anderson EJ, Ampofo K, Pavia AT, Arnold SR, McCullers JA, Williams DJ.

J Hosp Med. 2018 Dec 1;13(12):848-852. doi: 10.12788/jhm.3093. Epub 2018 Oct 31.

6.

C-Reactive Protein Predicts Risk of Venous Thromboembolism in Pediatric Musculoskeletal Infection.

Amaro E, Marvi TK, Posey SL, Benvenuti MA, An TJ, Dale KM, Lovejoy SA, Martus JE, Johnson ME, Mencio GA, Moore-Lotridge SN, Thomsen IP, Schoenecker JG.

J Pediatr Orthop. 2019 Jan;39(1):e62-e67. doi: 10.1097/BPO.0000000000001256.

PMID:
30300275
7.

Hierarchy of human IgG recognition within the Staphylococcus aureus immunome.

Radke EE, Brown SM, Pelzek AJ, Fulmer Y, Hernandez DN, Torres VJ, Thomsen IP, Chiang WK, Miller AO, Shopsin B, Silverman GJ.

Sci Rep. 2018 Sep 5;8(1):13296. doi: 10.1038/s41598-018-31424-3.

8.

Performance of TEM-PCR vs Culture for Bacterial Identification in Pediatric Musculoskeletal Infections.

Wood JB, Sesler C, Stalons D, Grigorenko E, Schoenecker JG, Creech CB, Thomsen IP.

Open Forum Infect Dis. 2018 May 22;5(6):ofy119. doi: 10.1093/ofid/ofy119. eCollection 2018 Jun 1.

9.

The Concern for Vancomycin Failure in the Treatment of Pediatric Staphylococcus aureus Disease.

Thomsen IP.

Clin Infect Dis. 2019 Jan 18;68(3):373-374. doi: 10.1093/cid/ciy497. No abstract available.

10.

Prevention of Infectious Complications in Patients With Chronic Granulomatous Disease.

Slack MA, Thomsen IP.

J Pediatric Infect Dis Soc. 2018 May 9;7(suppl_1):S25-S30. doi: 10.1093/jpids/piy016. Review.

11.

Noninfectious Manifestations and Complications of Chronic Granulomatous Disease.

Henrickson SE, Jongco AM, Thomsen KF, Garabedian EK, Thomsen IP.

J Pediatric Infect Dis Soc. 2018 May 9;7(suppl_1):S18-S24. doi: 10.1093/jpids/piy014. Review.

12.

Serologic Detection of Antibodies Targeting the Leukocidin LukAB Strongly Predicts Staphylococcus aureus in Children With Invasive Infection.

Wood JB, Jones LS, Soper NR, Xu M, Torres VJ, Buddy Creech C, Thomsen IP.

J Pediatric Infect Dis Soc. 2019 May 11;8(2):128-135. doi: 10.1093/jpids/piy017.

13.

Human Memory B Cells Targeting Staphylococcus aureus Exotoxins Are Prevalent with Skin and Soft Tissue Infection.

Pelzek AJ, Shopsin B, Radke EE, Tam K, Ueberheide BM, Fenyƶ D, Brown SM, Li Q, Rubin A, Fulmer Y, Chiang WK, Hernandez DN, El Bannoudi H, Sause WE, Sommerfield A, Thomsen IP, Miller AO, Torres VJ, Silverman GJ.

MBio. 2018 Mar 13;9(2). pii: e02125-17. doi: 10.1128/mBio.02125-17.

14.

Targeting fundamental pathways to disrupt Staphylococcus aureus survival: clinical implications of recent discoveries.

Thomsen IP, Liu GY.

JCI Insight. 2018 Mar 8;3(5). pii: 98216. doi: 10.1172/jci.insight.98216. Review.

15.

Antibody-based intervention against the pore-forming toxins of Staphylococcus aureus.

Thomsen IP.

Virulence. 2018 Dec 31;9(1):645-647. doi: 10.1080/21505594.2017.1421831. No abstract available.

16.

Commercial Intravenous Immunoglobulin Preparations Contain Functional Neutralizing Antibodies against the Staphylococcus aureus Leukocidin LukAB (LukGH).

Wood JB, Jones LS, Soper NR, Nagarsheth M, Creech CB, Thomsen IP.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e00968-17. doi: 10.1128/AAC.00968-17. Print 2017 Nov.

17.

Similar Clinical Severity and Outcomes for Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Pediatric Musculoskeletal Infections.

An TJ, Benvenuti MA, Mignemi ME, Martus J, Wood JB, Thomsen IP, Schoenecker JG.

Open Forum Infect Dis. 2017 Feb 9;4(1):ofx013. doi: 10.1093/ofid/ofx013. eCollection 2017 Winter.

18.

Monoclonal Antibodies Against the Staphylococcus aureus Bicomponent Leukotoxin AB Isolated Following Invasive Human Infection Reveal Diverse Binding and Modes of Action.

Thomsen IP, Sapparapu G, James DBA, Cassat JE, Nagarsheth M, Kose N, Putnam N, Boguslawski KM, Jones LS, Wood JB, Creech CB, Torres VJ, Crowe JE Jr.

J Infect Dis. 2017 Apr 1;215(7):1124-1131. doi: 10.1093/infdis/jix071.

19.

Pediatric Musculoskeletal Infection: Hijacking the Acute-Phase Response.

An TJ, Benvenuti MA, Mignemi ME, Thomsen IP, Schoenecker JG.

JBJS Rev. 2016 Sep 27;4(9). pii: 01874474-201609000-00001. doi: 10.2106/JBJS.RVW.15.00099.

PMID:
27760072
20.

Effects of Antibiotic Timing on Culture Results and Clinical Outcomes in Pediatric Musculoskeletal Infection.

Benvenuti MA, An TJ, Mignemi ME, Martus JE, Thomsen IP, Schoenecker JG.

J Pediatr Orthop. 2016 Sep 22. [Epub ahead of print]

PMID:
27662389
21.

Best Practices for Treatment of Invasive Methicillin-Susceptible Staphylococcus aureus Infections: The Case for Oxacillin.

Wood JB, Thomsen IP, Creech CB, Newland JG.

J Pediatric Infect Dis Soc. 2016 Dec;5(4):480-482. Epub 2016 Sep 7. No abstract available.

PMID:
27609072
22.

A Novel Classification System Based on Dissemination of Musculoskeletal Infection is Predictive of Hospital Outcomes.

Mignemi ME, Benvenuti MA, An TJ, Martus JE, Mencio GA, Lovejoy SA, Copley LA, Williams DJ, Thomsen IP, Schoenecker JG.

J Pediatr Orthop. 2018 May/Jun;38(5):279-286. doi: 10.1097/BPO.0000000000000811.

PMID:
27299780
23.

A Comprehensive Approach to the Management of Children and Adults with Chronic Granulomatous Disease.

Thomsen IP, Smith MA, Holland SM, Creech CB.

J Allergy Clin Immunol Pract. 2016 Nov - Dec;4(6):1082-1088. doi: 10.1016/j.jaip.2016.03.021. Epub 2016 May 10. Review.

PMID:
27178966
24.

Host response to Staphylococcus aureus cytotoxins in children with cystic fibrosis.

Chadha AD, Thomsen IP, Jimenez-Truque N, Soper NR, Jones LS, Sokolow AG, Torres VJ, Creech CB.

J Cyst Fibros. 2016 Sep;15(5):597-604. doi: 10.1016/j.jcf.2015.12.023. Epub 2016 Jan 25.

25.

Massive Ferritin Elevation in Neonatal Herpes Simplex Virus Infection: Hemophagocytic Lymphohistiocytosis or Herpes Simplex Virus Alone?

Vladescu IA, Browning WL, Thomsen IP.

J Pediatric Infect Dis Soc. 2015 Sep;4(3):e48-52. doi: 10.1093/jpids/piv005. Epub 2015 Feb 20. No abstract available.

PMID:
26407444
26.

Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial.

Jackson LA, Campbell JD, Frey SE, Edwards KM, Keitel WA, Kotloff KL, Berry AA, Graham I, Atmar RL, Creech CB, Thomsen IP, Patel SM, Gutierrez AF, Anderson EL, El Sahly HM, Hill H, Noah DL, Bellamy AR.

JAMA. 2015 Jul 21;314(3):237-46. doi: 10.1001/jama.2015.7916.

PMID:
26197184
27.

Polymyxin B infusion leading to cardiac arrest: a case report and literature review.

Berie MB, King MS, Thomsen IP.

Infection. 2015 Feb;43(1):121-4. doi: 10.1007/s15010-014-0704-3. Epub 2014 Nov 15.

PMID:
25398485
28.

Novel risk factors for recurrent Clostridium difficile infection in children.

Nicholson MR, Thomsen IP, Slaughter JC, Creech CB, Edwards KM.

J Pediatr Gastroenterol Nutr. 2015 Jan;60(1):18-22. doi: 10.1097/MPG.0000000000000553.

29.

Children with invasive Staphylococcus aureus disease exhibit a potently neutralizing antibody response to the cytotoxin LukAB.

Thomsen IP, Dumont AL, James DB, Yoong P, Saville BR, Soper N, Torres VJ, Creech CB.

Infect Immun. 2014 Mar;82(3):1234-42. doi: 10.1128/IAI.01558-13. Epub 2013 Dec 30.

30.

Controversies Surrounding Clostridium difficile Infection in Infants and Young Children.

Nicholson MR, Thomsen IP, Edwards KM.

Children (Basel). 2014 Jun 13;1(1):40-7. doi: 10.3390/children1010040. Review.

31.

[Physiotherapists in primary health care: close cooperation saves patient's time and is professionally instructive].

Thomsen IP.

Sygeplejersken. 1976 Feb 25;76(8):12-3. Danish. No abstract available.

PMID:
1045605

Supplemental Content

Loading ...
Support Center